ellie md glp 1 EllieMD EllieMD | Weight Loss -
Description
History of pancreatitis is a relative contraindication
While medications may share GLP-1 receptor activity, FDA approval applies to specific products and patient populations studied in clinical trials
Slow and steady discontinuation Stopping GLP-1 medications abruptly may lead to rapid weight regain
When tirzepatide was on the FDA drug shortage list, Section 503A of the Federal Food, Drug, and Cosmetic Act allowed licensed compounding pharmacies to produce compounded versions
doi: 10.1111/andr.12871 16 CawthonC
PMCID: PMC8074239
